| 1 | [SID103503976] | Active | IC50 | 4.2 | Inhibition of [3H]hypoxanthine uptake in Plasmodium falciparum 3D7 [AID274547, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Active | | IC50 | 4.2 [uM] | | BioAssay | Inhibition of [3H]hypoxanthine uptake in Plasmodium falciparum 3D7 | | AID | 274547 | | BioAssay type | Literature | | Target | | | PubMed | 17149876 | | Data Table |  |
|
| 2 | [SID103503976] | Active | Ki | 17 | Tested for its ability to inhibit calf spleen purine nucleoside phosphorylase (PNP) [AID164770, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Active | | Ki | 17 [uM] | | BioAssay | Tested for its ability to inhibit calf spleen purine nucleoside phosphorylase (PNP) | | AID | 164770 | | BioAssay type | Literature | | Target | | | PubMed | 8057293 | | Data Table |  |
|
| 3 | [SID26749634] | Active | Potency | 79.4328 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 4 | [SID103503976] | Active | Ki | | Inhibition of Plasmodium falciparum HGXPRT at pH 7.4 [AID274550, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Active | | Ki | [uM] | | BioAssay | Inhibition of Plasmodium falciparum HGXPRT at pH 7.4 | | AID | 274550 | | BioAssay type | Literature | | Target | | | PubMed | 17149876 | | Data Table |  |
|
| 5 | [SID103503976] | Active | | | Inhibition of Plasmodium falciparum HGXPRT at pH 8.5 [AID274563, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Active | | BioAssay | Inhibition of Plasmodium falciparum HGXPRT at pH 8.5 | | AID | 274563 | | BioAssay type | Literature | | Target | | | PubMed | 17149876 | | Data Table |  |
|
| 6 | [SID103503976] | Active | | | Inhibition of human HGPRT at pH 8.5 [AID274562, Type: Literature] | Hypoxanthine-guanine phosphoribosyltransferase [gi:123497] |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Active | | BioAssay | Inhibition of human HGPRT at pH 8.5 | | AID | 274562 | | BioAssay type | Literature | | Target | Hypoxanthine-guanine phosphoribosyltransferase [gi:123497] | | PubMed | 17149876 | | Data Table |  |
|
| 7 | [SID103503976] | Active | | | Inhibition of human HGPRT at pH 7.4 [AID274549, Type: Literature] | Hypoxanthine-guanine phosphoribosyltransferase [gi:123497] |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Active | | BioAssay | Inhibition of human HGPRT at pH 7.4 | | AID | 274549 | | BioAssay type | Literature | | Target | Hypoxanthine-guanine phosphoribosyltransferase [gi:123497] | | PubMed | 17149876 | | Data Table |  |
|
| 8 | [SID46393408] | Active | | | Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature] | Chain A, Purine Nucleoside Phosphorylase [gi:157834116] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 46393408 | | CID | 790 | | Outcome | Active | | BioAssay | Experimentally measured binding affinity data derived from PDB | | AID | 1811 | | BioAssay type | Literature | | Target | Chain A, Purine Nucleoside Phosphorylase [gi:157834116] | | PubMed | 9020983 | | Data Table |  |
|
| 9 | [SID103503976] | Unspecified | IC50 | 700 | Displacement of [3H]diazepam from benzodiazepine receptor in rat cerebral cortex membrane [AID401477, Type: other] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Unspecified | | IC50 | 700 [uM] | | BioAssay | Displacement of [3H]diazepam from benzodiazepine receptor in rat cerebral cortex membrane | | AID | 401477 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID103503976] | Unspecified | | | Insulin release in rat pancreatic beta-cells after 15 minutes of administration at 1 mM was measured [AID252792, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Unspecified | | BioAssay | Insulin release in rat pancreatic beta-cells after 15 minutes of administration at 1 mM was measured | | AID | 252792 | | BioAssay type | Literature | | Target | | | PubMed | 15686937 | | Data Table |  |
|
| 11 | [SID103503976] | Unspecified | | | Protection against 40 nM methotrexate-induced growth inhibition of human CCRF-CEM cells at 10 uM relative to control [AID282398, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Unspecified | | BioAssay | Protection against 40 nM methotrexate-induced growth inhibition of human CCRF-CEM cells at 10 uM relative to control | | AID | 282398 | | BioAssay type | Literature | | Target | | | PubMed | 15615522 | | Data Table |  |
|
| 12 | [SID103503976] | Unspecified | | | Protection against 5000 nM N-[4-[(2-amino-6-methyl-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-yl)thio]-2fluorobenzoyl]-L-glutamic acid-induced growth inhibition of human CCRF-CEM cells at 10 uM relative to control [AID282400, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Unspecified | | BioAssay | Protection against 5000 nM N-[4-[(2-amino-6-methyl-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-yl)thio]-2fluorobenzoyl]-L-glutamic acid-induced growth inhibition of human CCRF-CEM cells at 10 uM relative to control | | AID | 282400 | | BioAssay type | Literature | | Target | | | PubMed | 15615522 | | Data Table |  |
|
| 13 | [SID103503976] | Unspecified | | | Protection against 2400 nM N-[4-[(2-amino-6-methyl-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-yl)thio]-2chlorobenzoyl]-L-glutamic acid-induced growth inhibition of human CCRF-CEM cells at 10 uM relative to control [AID282402, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Unspecified | | BioAssay | Protection against 2400 nM N-[4-[(2-amino-6-methyl-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-yl)thio]-2chlorobenzoyl]-L-glutamic acid-induced growth inhibition of human CCRF-CEM cells at 10 uM relative to control | | AID | 282402 | | BioAssay type | Literature | | Target | | | PubMed | 15615522 | | Data Table |  |
|
| 14 | [SID103503976] | Unspecified | | | Growth inhibition of human CCRF-CEM cells at 10 uM relative to leucovorin [AID282410, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Unspecified | | BioAssay | Growth inhibition of human CCRF-CEM cells at 10 uM relative to leucovorin | | AID | 282410 | | BioAssay type | Literature | | Target | | | PubMed | 15615522 | | Data Table |  |
|
| 15 | [SID103503976] | Unspecified | | | Protection against 4000 nM N-{4-[(2,4-diamino-5-methyl-4, 7-dihydro-3H-pyrrolo[2,3-d]pyr imidin-6-yl)thio]benzoyl}-L-gl utamic acid-induced growth inhibition in human CCRF-CEM cells assessed as growth at 10 uM relative to control [AID282809, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Unspecified | | BioAssay | Protection against 4000 nM N-{4-[(2,4-diamino-5-methyl-4, 7-dihydro-3H-pyrrolo[2,3-d]pyr imidin-6-yl)thio]benzoyl}-L-gl utamic acid-induced growth inhibition in human CCRF-CEM cells assessed as growth at 10 uM relative to control | | AID | 282809 | | BioAssay type | Literature | | Target | | | PubMed | 16279780 | | Data Table |  |
|
| 16 | [SID103503976] | Unspecified | | | Protection against 40 nM methotrexate-induced growth inhibition in human CCRF-CEM cells assessed as growth at 10 uM relative to control [AID282810, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Unspecified | | BioAssay | Protection against 40 nM methotrexate-induced growth inhibition in human CCRF-CEM cells assessed as growth at 10 uM relative to control | | AID | 282810 | | BioAssay type | Literature | | Target | | | PubMed | 16279780 | | Data Table |  |
|
| 17 | [SID103503976] | Unspecified | | | Inhibition of phosphatidylinositol 4-kinase in human A431 cell membrane by liquid scintillation counting [AID338748, Type: other] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Unspecified | | BioAssay | Inhibition of phosphatidylinositol 4-kinase in human A431 cell membrane by liquid scintillation counting | | AID | 338748 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID26749634] | Unspecified | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Unspecified | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 19 | [SID103503976] | Unspecified | | | The concentration required to inhibit the growth of L-1210 leukemic cells was evaluated [AID97843, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Unspecified | | BioAssay | The concentration required to inhibit the growth of L-1210 leukemic cells was evaluated | | AID | 97843 | | BioAssay type | Literature | | Target | | | PubMed | 3981534 | | Data Table |  |
|
| 20 | [SID103503976] | Unspecified | | | The concentration required (hypoxanthine+uridine) to inhibit the growth of L-1210 leukemic cells was evaluated [AID97848, Type: Literature] | |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Unspecified | | BioAssay | The concentration required (hypoxanthine+uridine) to inhibit the growth of L-1210 leukemic cells was evaluated | | AID | 97848 | | BioAssay type | Literature | | Target | | | PubMed | 3981534 | | Data Table |  |
|
| 21 | [SID103503976] | Unspecified | | | Ratio of Ki values for guanine and related hypoxanthines in PNP inhibition assay [AID230017, Type: Literature] | Purine nucleoside phosphorylase [gi:205829287] |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103503976 | | CID | 790 | | Outcome | Unspecified | | BioAssay | Ratio of Ki values for guanine and related hypoxanthines in PNP inhibition assay | | AID | 230017 | | BioAssay type | Literature | | Target | Purine nucleoside phosphorylase [gi:205829287] | | PubMed | 8057293 | | Data Table |  |
|
| 22 | [SID26749634] | Inactive | Potency | | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation [AID492961, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation | | AID | 492961 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 23 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore) [AID875, Type: confirmatory] | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore) | | AID | 875 | | BioAssay type | confirmatory | | Target | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] | | PubMed | | | Data Table |  |
|
| 24 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore) [AID892, Type: confirmatory] | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore) | | AID | 892 | | BioAssay type | confirmatory | | Target | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] | | PubMed | | | Data Table |  |
|
| 25 | [SID11536560] | Inactive | | | NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR [AID1648, Type: other] | Chain A, Nmr Solution Structure Of The Frb Domain Of Mtor [gi:159164579] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 11536560 | | CID | 790 | | Outcome | Inactive | | BioAssay | NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR | | AID | 1648 | | BioAssay type | other | | Target | Chain A, Nmr Solution Structure Of The Frb Domain Of Mtor [gi:159164579] | | PubMed | | | Data Table |  |
|
| 26 | [SID11538005] | Inactive | | | NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR [AID1648, Type: other] | Chain A, Nmr Solution Structure Of The Frb Domain Of Mtor [gi:159164579] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 11538005 | | CID | 790 | | Outcome | Inactive | | BioAssay | NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR | | AID | 1648 | | BioAssay type | other | | Target | Chain A, Nmr Solution Structure Of The Frb Domain Of Mtor [gi:159164579] | | PubMed | | | Data Table |  |
|
| 27 | [SID26749634] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table |  |
|
| 28 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 29 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 [AID893, Type: confirmatory] | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 | | AID | 893 | | BioAssay type | confirmatory | | Target | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] | | PubMed | | | Data Table |  |
|
| 30 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 31 | [SID26749634] | Inactive | Potency | | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 32 | [SID26749634] | Inactive | Potency | | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) [AID1476, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) | | AID | 1476 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 33 | [SID26749634] | Inactive | Potency | | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) [AID1478, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) | | AID | 1478 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 34 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 35 | [SID26749634] | Inactive | Potency | | qHTS Assay for Modulators of Lamin A Splicing [AID1487, Type: confirmatory] | prelamin-A/C isoform 3 [Homo sapiens] [gi:27436948] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Modulators of Lamin A Splicing | | AID | 1487 | | BioAssay type | confirmatory | | Target | prelamin-A/C isoform 3 [Homo sapiens] [gi:27436948] | | PubMed | | | Data Table |  |
|
| 36 | [SID26749634] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 37 | [SID26749634] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 38 | [SID26749634] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 39 | [SID26749634] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 40 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide [AID1766, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide | | AID | 1766 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 41 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide [AID1768, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide | | AID | 1768 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 42 | [SID26749634] | Inactive | Potency | | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction [AID2662, Type: confirmatory] | MLL gene product [Homo sapiens] [gi:56550039] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction | | AID | 2662 | | BioAssay type | confirmatory | | Target | MLL gene product [Homo sapiens] [gi:56550039] | | PubMed | | | Data Table |  |
|
| 43 | [SID26749634] | Inactive | Potency | | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression [AID624263, Type: confirmatory] | Parkin [Homo sapiens] [gi:3063388] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression | | AID | 624263 | | BioAssay type | confirmatory | | Target | Parkin [Homo sapiens] [gi:3063388] | | PubMed | | | Data Table |  |
|
| 44 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 45 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 46 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 47 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 48 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 49 | [SID26749634] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26749634 | | CID | 790 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 50 | [SID26613338] | Inactive | | | Modulators of the EP2 prostaglandin E2 receptor - Primary Screening [AID940, Type: screening] | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26613338 | | CID | 790 | | Outcome | Inactive | | BioAssay | Modulators of the EP2 prostaglandin E2 receptor - Primary Screening | | AID | 940 | | BioAssay type | screening | | Target | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] | | PubMed | | | Data Table |  |
|